Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients

AIMS: Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor prognosis, especially in acute decompensated HF. However, there are no data on chronic HF patients. The aim is...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Marcondes‐Braga, Fabiana G., Gioli‐Pereira, Luciana, Bernardez‐Pereira, Sabrina, Batista, Guilherme L., Mangini, Sandrigo, Issa, Victor S., Fernandes, Fabio, Bocchi, Edimar A., Ayub‐Ferreira, Silvia M., Mansur, Alfredo J., Gutz, Ivano G.R., Krieger, Jose E., Pereira, Alexandre C., Bacal, Fernando
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373929/
https://ncbi.nlm.nih.gov/pubmed/32383349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12736
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi